Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with…
DENVER, Sept. 19, 2025 /PRNewswire/ -- Action for Healthy Kids (AFHK), a national nonprofit that partners with school districts, families,…
Virtual psychiatry leader honored for redefining access, scale, and quality in mental health care through its clinician-led modelNEW YORK, Sept.…
MESA, ARIZONA / ACCESS Newswire / September 18, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE), a leader in AI-powered…
Rethink Impact leads investment round as company targets expansion to 30+ states by end of 2026 WASHINGTON, DC / ACCESS…
5-year UG3/UH3 grant will fund the optimization and early-stage development of atai’s novel 5-HT2A/2C receptor agonists with non-hallucinogenic potential for…
Trusted Partnership Connects HIPAA Compliance Leader with Specialized EMR/EHR Provider for Integrative Medicine HUNTINGTON, N.Y. and NASHVILLE, Tenn., Sept. 18,…
NEW YORK, Sept. 17, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global digital…
Survey reveals surprising openness to AI surveillance for early detection, but consumers draw a hard line at automated decision-making AUSTIN,…
BOSTON, Sept. 17, 2025 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science…